Christopher Peetz

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Foster City, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Judit Ryvkin, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Christopher Peetz

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

Mirum Pharmaceuticals, Inc.

Security class
Restricted Stock Units
Shares / value
43,500
Estimated value
$1,198,108
Report date
28 Jan 2026
Price
$47.92
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ALPINE IMMUNE SCIENCES, INC.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
20 May 2024
Price
$6.33
Ownership
Christopher Peetz & Christine Peetz TR UA 02/15/2017 The Peetz Living Trust
Form 4 holding CHIEF EXECUTIVE OFFICER, Director

Mirum Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
67,000
Estimated value
Report date
28 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF EXECUTIVE OFFICER, Director

Mirum Pharmaceuticals, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
58,487
Estimated value
Report date
01 Sep 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF EXECUTIVE OFFICER, Director

Mirum Pharmaceuticals, Inc.

Security class
Performance Restricted Stock Units
Shares / value
25,000
Estimated value
Report date
15 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ALPINE IMMUNE SCIENCES, INC.

Security class
Stock Option (Right to buy)
Shares / value
0
Estimated value
Report date
20 May 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Christopher Peetz

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .